New disease severity classification of patients with stable chronic obstructive pulmonary disease in Shanghai

被引:4
|
作者
Xie Guogang [1 ]
Zhang Yingying [1 ]
Zhou Xin [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Resp Med, Shanghai 200080, Peoples R China
关键词
chronic obstructive pulmonary disease; Global Initiative for Chronic Obstructive Lung Disease; chronic obstructive pulmonary disease assessment test; exacerbation; lung function test; HEALTH-STATUS; LUNG-FUNCTION; COPD; EXACERBATION; PREDICTION; PROPIONATE; DECLINE; COHORT;
D O I
10.3760/cma.j.issn.0366-6999.20141206
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The Global Initiative for Chronic Obstructive Lung Disease (GOLD) presented a new ABCD group classification of chronic obstructive pulmonary disease (COPD). We aimed to examine the association of spirometric classification and the new GOLD classification with exacerbations, and to compare symptoms in different ways. Methods We investigated 848 patients with stable COPD from 24 hospitals. The annual frequencies of acute exacerbation and hospitalization were compared between the old and new classification. The symptom level was assessed using COPD assessment test (CAT) and modified British Medical Research Council (mMRC) questionnaire. Results A total of 848 patients were included in this study. According to spirometric classification, there were 32 patients of grade I (3.8%), 315 of grade II (37.1%), 366 of grade III (43.2%), and 135 of grade IV (15.9%). According to GOLD 2011 classification, there were 59 patients of group A (7.0%), 172 of group B (20.3%), 55 of group C (6.5%), and 562 of group D (66.3%). In spirometric classification, the annual frequencies of acute exacerbation and associated hospitalization were respectively 1 (0-3) and 0 (0-2) for grade I; 1 (0-5) and 0 (0-2) for grade II; 2 (0-6) and 1 (0-3) for grade III, and 3 (0-6) and 2 (0-3) for grade IV. In GOLD 2011, respectively 0 (0-3) and 0 (0-1) (group A), 1 (0-4) and 0 (0-3) (group B), 1 (0-5) and 0 (0-3) (group C), and 3 (0-6) and 1 (0-3) (group D). There were no significant difference between group B and C (Z=similar to 1.347, P=0.178; Z= -0.772, P=0.440, respectively). The coincidence rate using mMRC=1 and CAT=10 as cutoff points was 86.6% (734/848, kappa=0.706), compared with 77.9% (661/848, kappa=0.60) using mMRC=2 and CAT=10. Conclusions Lung function test may be a better predictor of acute exacerbation and associated hospitalization of COPD. It is more appropriate to use mMRC=1 as cutoff point for assessing COPD symptoms.
引用
收藏
页码:3046 / 3050
页数:5
相关论文
共 50 条
  • [1] Chronic obstructive pulmonary disease - diagnosis and classification of severity
    Viviers, P. J.
    van Zyl-Smit, R. N.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2015, 105 (09): : 786 - 788
  • [2] The severity of sleep hypoventilation in stable chronic obstructive pulmonary disease
    Ellingsen, Ivar
    Fondenes, Ove
    Overland, Britt
    Holmedahl, Nils Henrik
    SLEEP AND BREATHING, 2021, 25 (01) : 243 - 249
  • [3] The severity of sleep hypoventilation in stable chronic obstructive pulmonary disease
    Ivar Ellingsen
    Ove Fondenes
    Britt Øverland
    Nils Henrik Holmedahl
    Sleep and Breathing, 2021, 25 : 243 - 249
  • [4] Association of Depression with Disease Severity in Patients with Chronic Obstructive Pulmonary Disease
    Ki Uk Kim
    Hye-Kyung Park
    Hee Young Jung
    Jong-Joon Ahn
    Eunsoo Moon
    Yun Seong Kim
    Min Ki Lee
    Haejung Lee
    Lung, 2014, 192 : 243 - 249
  • [5] Association of Depression with Disease Severity in Patients with Chronic Obstructive Pulmonary Disease
    Kim, Ki Uk
    Park, Hye-Kyung
    Jung, Hee Young
    Ahn, Jong-Joon
    Moon, Eunsoo
    Kim, Yun Seong
    Lee, Min Ki
    Lee, Haejung
    LUNG, 2014, 192 (02) : 243 - 249
  • [6] Severity of Airflow Obstruction in Chronic Obstructive Pulmonary Disease (COPD): Proposal for a New Classification
    Coton, Sonia
    Vollmer, William M.
    Bateman, Eric
    Marks, Guy B.
    Tan, Wan
    Mejza, Filip
    Juvekar, Sanjay
    Janson, Christer
    Mortimer, Kevin
    Mahesh, P. A.
    Buist, A. Sonia
    Burney, Peter G. J.
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 14 (05) : 469 - 475
  • [7] Arrhythmogenesis in patients with stable chronic obstructive pulmonary disease
    Theofilogiannakos, Efstratios K.
    Anogeianaki, Antonia
    Tsekoura, Panagiota
    Glouftsios, Petros
    Ilonidis, George
    Hatzitolios, Apostolos
    Anogianakis, George
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2008, 9 (01) : 89 - 93
  • [8] Markers of disease severity in chronic obstructive pulmonary disease
    Franciosi, LG
    Page, CP
    Celli, BR
    Cazzola, M
    Walker, MJ
    Danhot, M
    Rabe, KF
    Della Pasqua, OE
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2006, 19 (03) : 189 - 199
  • [9] Comparing frequencies of asthma-chronic obstructive pulmonary disease overlap in patients with stable chronic obstructive pulmonary disease
    Nezar R. Mohamed
    Mohamed A. E. Abd El Hakim
    Zainab H. Saeed
    Rofaida N. E. Helmy
    Egyptian Journal of Bronchology, 2019, 13 : 298 - 302
  • [10] Comparing frequencies of asthma-chronic obstructive pulmonary disease overlap in patients with stable chronic obstructive pulmonary disease
    Mohamed, Nezar R.
    Abd El Hakim, Mohamed A. E.
    Saeed, Zainab H.
    Helmy, Rofaida N. E.
    EGYPTIAN JOURNAL OF BRONCHOLOGY, 2019, 13 (03) : 298 - 302